Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Change in Inventory (2018 - 2025)

Dna X (SONM) has disclosed Change in Inventory for 8 consecutive years, with $968000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Inventory fell 88.7% year-over-year to $968000.0, compared with a TTM value of -$1.9 million through Sep 2025, down 120.69%, and an annual FY2024 reading of $5.0 million, up 91.45% over the prior year.
  • Change in Inventory was $968000.0 for Q3 2025 at Dna X, down from $1.3 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $8.6 million in Q3 2024 and bottomed at -$2.7 million in Q4 2021.
  • Average Change in Inventory over 5 years is $92894.7, with a median of -$180000.0 recorded in 2022.
  • The sharpest move saw Change in Inventory plummeted 383.28% in 2024, then skyrocketed 127000.0% in 2025.
  • Year by year, Change in Inventory stood at -$2.7 million in 2021, then skyrocketed by 93.44% to -$180000.0 in 2022, then skyrocketed by 1376.67% to $2.3 million in 2023, then crashed by 181.77% to -$1.9 million in 2024, then surged by 151.52% to $968000.0 in 2025.
  • Business Quant data shows Change in Inventory for SONM at $968000.0 in Q3 2025, $1.3 million in Q2 2025, and -$2.3 million in Q1 2025.